Accordingly, bortezomib has been shown to promote the surface translocation of CRT and HSP90, increasing DC phagocytosis of dying MM cells, which in turn was shown to increase effector memory CD4+ and CD8+ T cell responses in co-culture [165,166]. Here, CALR is linked to Miyoshi myopathy.